“China’s 2023 Evidence-Based Guidelines for Kawasaki Disease Diagnosis and Treatment in Children”

https://pubmed.ncbi.nlm.nih.gov/38112136

The “Evidence-based guidelines for the diagnosis and treatment of Kawasaki disease in children in China (2023)” provide 20 recommendations for standardizing the diagnosis, treatment, and long-term management of KD in China, with the goal of reducing the incidence of cardiac events and KD-related mortality in children with KD.